Meet the New Leadership at CBI's 7th Annual Pharma, Biotech and Device Corporate Tax Congress - June 6-7, 2012 in Washington, D.C.

WOBURN, Mass., April 25, 2012 /PRNewswire/ -- CBI has confirmed their speaker line-up of tax leaders for the upcoming 7th Annual Corporate Tax Congress, June 6-7, 2012, in Washington, D.C.

The roster includes: Marlies de Ruiter, the OECD's new Head of the Tax Treaty, Transfer Pricing and Financial Transactions Division of the Centre for Tax Policy and Administration, and Sergio Arellano, from the IRS's recently formed LB&I Division, who serves as Industry Director of Retailers, Food, Pharmaceuticals and Healthcare.

In addition, David P. Lewis of Eli Lilly and Company joins the Congress to deliver the Industry Keynote Address. Mr. Lewis is Vice President, Global Taxes, Chief Tax Executive and Assistant Treasurer at Eli Lilly and Company and also serves as Chairman of the PhRMA Tax Committee.

CBI's Tax Congress is the leading resource for life sciences corporate tax professionals. Led by in-house tax counsel from bio/pharmaceutical organizations, the agenda delves into the latest legislative proposals for corporate tax reform including: potential changes for MNCs, medical device excise taxes, Branded Prescription Drug Fee administration and international tax planning and transfer pricing.

For more information about the conference visit http://www.cbinet.com/tax

Contact: Kristina Weljkovic  
Phone number: 339-298-2285
Email address: [email protected]

This press release was issued through eReleases(R).  For more information, visit eReleases Press Release Distribution at http://www.ereleases.com.

SOURCE CBI